MicroPort Endovascular MedTech Ltd (688016) — Cash Flow Quality Index
MicroPort Endovascular MedTech Ltd (688016) has a Cash Flow Quality Index of 0.41x as of September 2025. Operating cash flow of CN¥46.79 Million is below net income of CN¥114.41 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 688016 cash generation efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
MicroPort Endovascular MedTech Ltd Cash Flow Quality Index (2016–2025)
Historical Cash Flow Quality Index for MicroPort Endovascular MedTech Ltd across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check total reinvestment intensity of MicroPort Endovascular MedTech Ltd to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for MicroPort Endovascular MedTech Ltd (2016–2025)
Year-by-year earnings quality comparison for MicroPort Endovascular MedTech Ltd. For live market cap and the full company financial profile, see market cap of MicroPort Endovascular MedTech Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.02x | CN¥573.06 Million | CN¥563.21 Million | ▲ +34.2% |
| 2024 | 0.76x | CN¥373.60 Million | CN¥492.75 Million | ▼ -34.6% |
| 2023 | 1.16x | CN¥571.22 Million | CN¥492.43 Million | ▲ +22.4% |
| 2022 | 0.95x | CN¥333.76 Million | CN¥352.05 Million | ▼ -1.0% |
| 2021 | 0.96x | CN¥300.25 Million | CN¥313.51 Million | ▼ -5.5% |
| 2020 | 1.01x | CN¥217.44 Million | CN¥214.61 Million | ▲ +0.3% |
| 2019 | 1.01x | CN¥143.20 Million | CN¥141.76 Million | ▼ -14.3% |
| 2018 | 1.18x | CN¥106.85 Million | CN¥90.65 Million | ▲ +7.7% |
| 2017 | 1.09x | CN¥69.36 Million | CN¥63.39 Million | ▲ +49.3% |
| 2016 | 0.73x | CN¥30.13 Million | CN¥41.11 Million | — |